and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.
作者信息
Andersen Michael Asger, Eriksen Casper Tabassum, Brieghel Christian, Biccler Jorne Lionel, Cunha-Bang Caspar da, Helleberg Marie, Niemann Carsten Utoft
机构信息
Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark.
Department of Hematology, Aalborg University Hospital, Denmark.
出版信息
Haematologica. 2018 Jul;103(7):e300-e303. doi: 10.3324/haematol.2017.182006. Epub 2018 Mar 8.
Abstract
摘要
相似文献
1
and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.慢性淋巴细胞白血病患者治疗前感染的预测因素：一项丹麦全国队列研究。
Haematologica. 2018 Jul;103(7):e300-e303. doi: 10.3324/haematol.2017.182006. Epub 2018 Mar 8.
2
Complications of chronic lymphocytic leukemia: analysis of 203 cases in China.慢性淋巴细胞白血病的并发症：中国203例病例分析
Leuk Res. 2010 Feb;34(2):e64-5. doi: 10.1016/j.leukres.2009.07.041. Epub 2009 Aug 21.
3
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.免疫球蛋白VH基因突变状态及其他预后因素对慢性淋巴细胞白血病患者严重感染发生率的影响。
Cancer. 2006 Sep 1;107(5):1023-33. doi: 10.1002/cncr.22094.
4
Caring for patients with chronic lymphocytic leukemia.护理慢性淋巴细胞白血病患者。
Clin J Oncol Nurs. 2008 Jun;12(3):417-23. doi: 10.1188/08.CJON.417-423.
5
Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者非诱发性静脉血栓栓塞事件的发生率
Leuk Lymphoma. 2018 Feb;59(2):509-511. doi: 10.1080/10428194.2017.1341979. Epub 2017 Jun 27.
6
A link between hypercholesterolemia and chronic lymphocytic leukemia.高胆固醇血症与慢性淋巴细胞白血病之间的联系。
Leuk Lymphoma. 2016;57(4):797-802. doi: 10.3109/10428194.2015.1088651. Epub 2015 Oct 9.
7
Chronic lymphocytic leukemia: the most common leukemia in adults.慢性淋巴细胞白血病：成人中最常见的白血病。
JAAPA. 2011 May;24(5):54-8 Quiz 59. doi: 10.1097/01720610-201105000-00009.
8
Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up.
Haematologica. 1993 Nov-Dec;78(6):374-7.
9
Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism.慢性淋巴细胞白血病是静脉血栓栓塞的一个风险因素。
Leuk Res. 2011 Mar;35(3):419-21. doi: 10.1016/j.leukres.2010.11.011. Epub 2010 Dec 14.
10
Evidence of an association between non-Hodgkin's lymphoma and skin cancer.非霍奇金淋巴瘤与皮肤癌之间存在关联的证据。
BMJ. 1995 Jun 10;310(6993):1491-5. doi: 10.1136/bmj.310.6993.1491.
引用本文的文献
1
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era.慢性淋巴细胞白血病中新冠疫情的结果：聚焦极早期和奥密克戎时代。
Blood Adv. 2025 Jul 8;9(13):3170-3181. doi: 10.1182/bloodadvances.2024015260.
2
[Single-center study of COVID-19 in patients with chronic lymphocytic leukemia].慢性淋巴细胞白血病患者新冠病毒病的单中心研究
Zhonghua Xue Ye Xue Za Zhi. 2024 Oct 14;45(10):923-930. doi: 10.3760/cma.j.cn121090-20240621-00230.
3
Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and Sweden.丹麦、芬兰、挪威和瑞典慢性淋巴细胞白血病诊断与生存之间的复杂关系。
Cancers (Basel). 2024 Sep 22;16(18):3229. doi: 10.3390/cancers16183229.
4
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma.慢性淋巴细胞白血病、非霍奇金淋巴瘤或多发性骨髓瘤诊断前的感染及其预后意义。
Br J Cancer. 2024 Oct;131(7):1186-1194. doi: 10.1038/s41416-024-02816-2. Epub 2024 Aug 22.
5
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy.慢性淋巴细胞白血病患者血清免疫球蛋白水平的综合评估：一线化疗免疫治疗后 IgA 显著升高。
Cancer Med. 2024 Aug;13(15):e7399. doi: 10.1002/cam4.7399.
6
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia.停止对无症状低危慢性淋巴细胞白血病的专业随访是可行且安全的。
Blood Adv. 2024 Aug 27;8(16):4449-4456. doi: 10.1182/bloodadvances.2023012382.
7
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.预测慢性淋巴细胞白血病中的严重感染：一种简单的风险评分，用于在诊断时对患者进行分层。
Ann Hematol. 2024 May;103(5):1655-1664. doi: 10.1007/s00277-024-05625-y. Epub 2024 Jan 18.
8
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia.多中心随机对照试验方案，旨在研究暂时暂停布鲁顿酪氨酸激酶抑制剂治疗以与 SARS-CoV-2 疫苗接种同步进行及其对慢性淋巴细胞白血病患者免疫反应的影响。
BMJ Open. 2023 Sep 28;13(9):e077946. doi: 10.1136/bmjopen-2023-077946.
9
Evaluation of the CLL-IPI and IPS-E Prognostic Indices in a Young Middle Eastern Population with Chronic Lymphocytic Leukemia: A Retrospective Analysis at the Kuwait Cancer Control Center.评估年轻中东人群慢性淋巴细胞白血病的 CLL-IPI 和 IPS-E 预后指数：科威特癌症控制中心的回顾性分析。
Med Princ Pract. 2023;32(3):192-199. doi: 10.1159/000533284. Epub 2023 Jul 28.
10
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.布鲁顿酪氨酸激酶抑制剂在B细胞淋巴瘤中的作用：超越抗肿瘤效应
Exp Hematol Oncol. 2022 Sep 22;11(1):60. doi: 10.1186/s40164-022-00315-9.
本文引用的文献
1
The Danish National Chronic Lymphocytic Leukemia Registry.丹麦国家慢性淋巴细胞白血病登记处。
Clin Epidemiol. 2016 Oct 25;8:561-565. doi: 10.2147/CLEP.S99486. eCollection 2016.
2
The CLL-IPI applied in a population-based cohort.CLL-IPI应用于一项基于人群的队列研究。
Blood. 2016 Oct 27;128(17):2181-2183. doi: 10.1182/blood-2016-07-724740. Epub 2016 Sep 7.
3
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.新诊断的慢性淋巴细胞白血病患者出现低丙种球蛋白血症是早期死亡的一个预测指标。
Leuk Lymphoma. 2016 Jul;57(7):1592-9. doi: 10.3109/10428194.2016.1142082. Epub 2016 Feb 5.
4
Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.接受依鲁替尼治疗的慢性淋巴细胞白血病患者体液免疫部分重建且感染减少。
Blood. 2015 Nov 5;126(19):2213-9. doi: 10.1182/blood-2015-04-639203. Epub 2015 Sep 3.
5
Utilization of blood cultures in Danish hospitals: a population-based descriptive analysis.丹麦医院血液培养的利用：基于人群的描述性分析。
Clin Microbiol Infect. 2015 Apr;21(4):344.e13-21. doi: 10.1016/j.cmi.2014.11.018. Epub 2014 Nov 23.
6
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.临床单克隆 B 细胞淋巴细胞增多症（MBL）患者的感染并发症：与对照相比，新诊断病例的队列研究。
Leukemia. 2013 Jan;27(1):136-41. doi: 10.1038/leu.2012.187. Epub 2012 Jul 11.
7
Monoclonal B-cell lymphocytosis: right track or red herring?单克隆 B 细胞淋巴增生症：正确的线索还是误导？
Blood. 2012 May 10;119(19):4358-62. doi: 10.1182/blood-2012-01-404681. Epub 2012 Mar 14.
8
Competing risks in epidemiology: possibilities and pitfalls.流行病学中的竞争风险：可能性与陷阱。
Int J Epidemiol. 2012 Jun;41(3):861-70. doi: 10.1093/ije/dyr213. Epub 2012 Jan 9.
9
Selective IgA deficiency.选择性 IgA 缺乏症。
J Clin Immunol. 2010 Jan;30(1):10-6. doi: 10.1007/s10875-009-9357-x. Epub 2010 Jan 26.
10
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.慢性淋巴细胞白血病患者的感染并发症：发病机制、感染谱及预防方法
Clin Lymphoma Myeloma. 2009 Oct;9(5):365-70. doi: 10.3816/CLM.2009.n.071.
Zotero 插件